Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 2Pregnancy Complications 1Menorrhagia 1Endometriosis 1

Interventions

Uterine Myomectomy 2relugolix 1elagolix 1Uterine Artery Embolization 1Radiofrequency Ablation 1Norethindrone Acetate 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Menorrhagia × Norethindrone Acetate × 1 year × Clear all
NCT03271489 2025-07-22

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

AbbVie

Phase 3 Completed
478 enrolled 9 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡